Septal Shift for the Diagnosis of COnstrictive Pericarditis: The Impact of Inspiratory Effort Quantification on Deep Breathing Manoeuvres
NCT ID: NCT02685371
Last Updated: 2018-09-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2016-09-30
2020-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Breath-hold Cardiac Hybrid SPECT/CCTA
NCT02469051
Clinical Echocardiography and S' Wave for Early Recognition of Acute Coronary Syndrome in the Emergency Department, A Prospective Study
NCT06860997
xSPECT-based Myocardial Perfusion Scintigraphy: Consistency of Functional Values and Feasibility of Myocardial Uptake Quantitation in Patients With Suspected Coronary Artery Disease
NCT04583787
Cardiac Autonomic Function in Women with Microvascular Coronary Dysfunction
NCT01568177
Leveraging Exercise Stress Echocardiography for Heart Failure With Preserved Ejection Fraction
NCT06927973
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Breathing effort type
Current known criteria for constrictive pericarditis will be test under: 1- spontaneous breathing 2- Breathing with a negative pressure of -15 to - 30 cm of water 3- Breathing with a negative pressure of more than - 30 cm of water.
Breathing
Subjects will have to breath 1- Spontaneously 2- to produce a negative pressure of -15 to -30 cm of water and 3- to produce a negative pressure more than -30 cm of water.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Breathing
Subjects will have to breath 1- Spontaneously 2- to produce a negative pressure of -15 to -30 cm of water and 3- to produce a negative pressure more than -30 cm of water.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal transthoracic echocardiogram if older than 41 years old
* Normal standardized history and physical examination
* Normal blood pressure (\<130/80)
* Normal 12-lead ECG at rest.
Exclusion Criteria
* Unexplained symptoms that could be related to a heart or pulmonary problems.
* Symptoms of or active cardiovascular or pulmonary problems
* Hepatic or kidney dysfunction
* Blood cell dyscrasia
* Cardiovascular risk factor (smoking, hypertension, dyslipidemia, diabetes)
* Obesity (BMI \> 30)
* Pregnancy or pregnancy in the last year
* Cardiac congenital anomalies discovered during the cardiovascular magnetic resonance
* Current medication with cardiovascular side effects known (diuretics, beta-blockers, calcium channel blockers)
* Contraindication to cardiovascular magnetic resonance
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Université de Sherbrooke
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Paul Farand
M.D.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Paul
Sherbrooke, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Paul Farand, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MP-31-2016-1083
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.